DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE6422.95-22.05 (-0.34 %)
PREV CLOSE ( ) 6445.00
OPEN PRICE ( ) 6400.35
BID PRICE (QTY) 6423.75 (10)
OFFER PRICE (QTY) 6426.75 (1)
VOLUME 5423
TODAY'S LOW / HIGH ( )6380.00 6490.00
52 WK LOW / HIGH ( )4298.4 6494.95
NSE6418.10-24.05 (-0.37 %)
PREV CLOSE( ) 6442.15
OPEN PRICE ( ) 6445.05
BID PRICE (QTY) 6418.10 (8)
OFFER PRICE (QTY) 6418.40 (1)
VOLUME 141223
TODAY'S LOW / HIGH( ) 6380.65 6490.00
52 WK LOW / HIGH ( )4297 6494.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email mail@drreddys.com / shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
12Feb IRCTC, Hero MotoCorp and RITES to see
Indian Railways Catering and Tourism Corporation (IRCTC) has incorporate..
12Feb Dr. Reddy's trades higher on the BSE
Dr. Reddy's Laboratories is currently trading at Rs. 6259.85, up by 107...
10Feb Dr. Reddy's gets EIR from USFDA for fo
Dr. Reddy's Laboratories has received Establishment Inspection Report (E..
31Jan Dr. Reddy’s Laboratories informs about
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
31Jan Dr.Reddy's Laboratories reports 11% ri
Dr. Reddy's Laboratories has reported results for third quarter ended De..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit475226128
Gross Profit 6319 38660
Operating Profit 883948061
Net Sales 41030169625
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
AMI Organics (BSE)
 1115.00 (3.72%)
M.Cap (Rs. in Cr)4119.01
Orchid Pharma (BSE)
 1250.80 (2.76%)
M.Cap (Rs. in Cr)6349.78
Concord Biotech (BSE)
 1505.00 (2.06%)
M.Cap (Rs. in Cr)15692.95
Bharat Parenterals (BSE)
 1050.00 (2.95%)
M.Cap (Rs. in Cr)611.06
Glenmark Pharma (BSE)
 927.50 (3.02%)
M.Cap (Rs. in Cr)26254.79
Shareholding Pattern
PROMOTERS 26.65%
NON-INSTITUTION 10.75%
MUTUAL FUNDS/UTI 8.22%
FI/BANKS/INSURANCE 7.99%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.